About the study The ESSENCE phase 3 clinical trial enrolled 800 participants at 253 sites across 37 countries
It is crucial to note that whilst these early findings are encouraging, GLP-1 agonists are not currently recommended or approved for AUD treatment by NICE, the MHRA, or other regulatory bodies
In addition, almost all patients achieved at least 5 % Weight loss, which is widely considered to be clinically relevant
Tirzepatide works by reducing appetite and improving insulin sensitivity, helping you lose weight more effectively
CollaSkin Veg : India's first Vegetarian Collagen supplement containing vegetarian collagen peptides, Vitamin C, E, and Hyaluronic Acid, proven to reduce wrinkles, improve skin texture, and enhance glow